☆ 4.7 Article

Analysis of intracellular tyrosine phosphorylation in circulating neutrophils as a rapid assay for the in vivo effect of oral tyrosine kinase inhibitors

FRONTIERS IN PHARMACOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Rheumatology

Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Maria Prendecki et al.

Summary: This study investigated the role of Syk in ANCA-induced myeloid cell activation and vasculitis pathogenesis. Increased phosphorylated Syk was found in neutrophils and monocytes from patients with active AAV. In vitro experiments demonstrated that Syk was phosphorylated following MPO-ANCA IgG stimulation and Syk inhibition could prevent ANCA-mediated cellular responses. Targeted gene expression analysis revealed up-regulation of FcR- and Syk-dependent signaling pathways. Syk expression and phosphorylation were also detected in tissue leukocytes at sites of organ inflammation in AAV.

ARTHRITIS & RHEUMATOLOGY (2023)

Add to Collection

Review Rheumatology

Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach

Yoshiya Tanaka et al.

Summary: This Review discusses the therapeutic use of Janus kinase inhibitors in autoimmune rheumatic diseases, highlighting their disease-specific mechanisms of action. JAK inhibitors suppress intracellular signaling mediated by multiple cytokines, offering potential treatment options for a range of immune and inflammatory disorders.

NATURE REVIEWS RHEUMATOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Why 90 % of clinical drug development fails and how to improve it?

Duxin Sun et al.

Summary: Despite the implementation of many successful strategies, the majority of clinical drug development fails. This study suggests that current drug optimization strategies overlook tissue exposure/selectivity, leading to misleading drug candidate selection and impacting clinical efficacy/toxicity balance. The proposed structure-tissue exposure/selectivity-activity relationship (STAR) classification system aims to improve drug optimization and enhance the success rate of clinical drug development.

ACTA PHARMACEUTICA SINICA B (2022)

Add to Collection

Article Fisheries

The role of Syk phosphorylation in Fc receptor mediated mIgM plus B lymphocyte phagocytosis in flounder (Paralichthys olivaceus)

Yanbo Hao et al.

Summary: The study reveals that phosphorylated Syk plays a key role in FcR-mediated phagocytosis and bactericidal activity of mIgM+ B lymphocytes, affecting intracellular reactive oxygen species levels and the expression of related genes.

FISH & SHELLFISH IMMUNOLOGY (2022)

Add to Collection

Review Biotechnology & Applied Microbiology

Kinase drug discovery 20 years after imatinib: progress and future directions

Philip Cohen et al.

Summary: Advances in improving the potency and specificity of small-molecule protein kinase inhibitors over the past 20 years have had a significant impact on the treatment of cancers and non-cancerous conditions. Efforts are being made to address the challenge of drug resistance to kinase inhibitors, and future directions in kinase drug discovery are being discussed.

NATURE REVIEWS DRUG DISCOVERY (2021)

Add to Collection

Review Oncology

Targeting FAK in anticancer combination therapies

John C. Dawson et al.

Summary: Focal adhesion kinase (FAK) is commonly overexpressed in cancer and involved in various oncogenic processes and resistance mechanisms, making FAK inhibitors most effective as combination therapies in selected patient populations.

NATURE REVIEWS CANCER (2021)

Add to Collection

Review Pharmacology & Pharmacy

Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems

Patrick M. Glassman et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Add to Collection

Article Cell Biology

A History of Cancer Research: Tyrosine Kinases

Joseph Lipsick

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2019)

Add to Collection

Article Immunology

Tofacitinib for the treatment of rheumatoid arthritis: an update

Kunihiro Yamaoka

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)

Add to Collection

Review Immunology

Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases

Kata P. Szilveszter et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Developmental Biology

Semi-automatized segmentation method using image-based flow cytometry to study sperm physiology: the case of capacitation-induced tyrosine phosphorylation

Arturo Matamoros-Volante et al.

MOLECULAR HUMAN REPRODUCTION (2018)

Add to Collection

Review Pharmacology & Pharmacy

Dasatinib: A Review in Chronic Myeloid Leukaemia and Ph plus Acute Lymphoblastic Leukaemia

Gillian M. Keating

DRUGS (2017)

Add to Collection

Article Biochemical Research Methods

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response

Xu Zhang et al.

MOLECULAR & CELLULAR PROTEOMICS (2017)

Add to Collection

Review Biotechnology & Applied Microbiology

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

Daniella M. Schwartz et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Add to Collection

Review Pharmacology & Pharmacy

Tofacitinib: A Review in Rheumatoid Arthritis

Sohita Dhillon

DRUGS (2017)

Add to Collection

Review Biotechnology & Applied Microbiology

Mitigating risk in academic preclinical drug discovery

Jayme L. Dahlin et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Add to Collection

Article Immunology

The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment

Miklos Kovacs et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2014)

Add to Collection

Letter Biotechnology & Applied Microbiology

Can you trust your animal study data?

Ian S. Peers et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Add to Collection

Article Cell Biology

Receptor Tyrosine Kinases: Legacy of the First Two Decades

Joseph Schlessinger

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Add to Collection

Review Oncology

RET revisited: expanding the oncogenic portfolio

Lois M. Mulligan

NATURE REVIEWS CANCER (2014)

Add to Collection

Article Hematology

Dasatinib inhibits proinflammatory functions of mature human neutrophils

Krisztina Futosi et al.

BLOOD (2012)

Add to Collection

Article Multidisciplinary Sciences

A Highly Scalable Peptide-Based Assay System for Proteomics

Igor A. Kozlov et al.

PLOS ONE (2012)

Add to Collection

Review Pharmacology & Pharmacy

Principles of early drug discovery

J. P. Hughes et al.

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Add to Collection

Article Biochemistry & Molecular Biology

Cell Signaling by Receptor Tyrosine Kinases

Mark A. Lemmon et al.

CELL (2010)

Add to Collection

Review Oncology

Imatinib and beyond-exploring the full potential of targeted therapy for CML

Alfonso Quintas-Cardama et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2009)

Add to Collection

Article Oncology

Flow Cytometric Determination of Src Phosphorylation in Pediatric Patients Treated With Dasatinib

Bella S. Guerrouahen et al.

PEDIATRIC BLOOD & CANCER (2009)

Add to Collection

Review Pharmacology & Pharmacy

Imatinib - A review of its use in chronic myeloid leukaemia

Marit D. Moen et al.

DRUGS (2007)

Add to Collection

Review Immunology

Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level

OD Perez et al.

IMMUNOLOGICAL REVIEWS (2006)

Add to Collection

Article Biochemical Research Methods

Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr-Abl-positive cells

V Desplat et al.

CYTOMETRY PART A (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.